SkyOak Wealth’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-8,029
| Closed | -$231K | – | 249 |
|
2024
Q1 | $231K | Buy |
8,029
+1,000
| +14% | +$28.8K | 0.06% | 216 |
|
2023
Q4 | $231K | Sell |
7,029
-3,500
| -33% | -$115K | 0.06% | 213 |
|
2023
Q3 | $293K | Sell |
10,529
-332
| -3% | -$9.25K | 0.09% | 170 |
|
2023
Q2 | $370K | Sell |
10,861
-2,000
| -16% | -$68.2K | 0.1% | 145 |
|
2023
Q1 | $387K | Sell |
12,861
-204
| -2% | -$6.13K | 0.12% | 137 |
|
2022
Q4 | $369K | Hold |
13,065
| – | – | 0.12% | 136 |
|
2022
Q3 | $429K | Sell |
13,065
-5,150
| -28% | -$169K | 0.15% | 117 |
|
2022
Q2 | $574K | Buy |
18,215
+10
| +0.1% | +$315 | 0.2% | 100 |
|
2022
Q1 | $836K | Buy |
18,205
+1,000
| +6% | +$45.9K | 0.23% | 95 |
|
2021
Q4 | $1.05M | Buy |
17,205
+1,000
| +6% | +$61.3K | 0.27% | 87 |
|
2021
Q3 | $1.21M | Hold |
16,205
| – | – | 0.33% | 73 |
|
2021
Q2 | $1.5M | Sell |
16,205
-175
| -1% | -$16.2K | 0.4% | 65 |
|
2021
Q1 | $1.5M | Buy |
16,380
+1,751
| +12% | +$160K | 0.42% | 65 |
|
2020
Q4 | $1.36M | Hold |
14,629
| – | – | 0.42% | 67 |
|
2020
Q3 | $932K | Sell |
14,629
-81
| -0.6% | -$5.16K | 0.34% | 76 |
|
2020
Q2 | $767K | Buy |
14,710
+4,650
| +46% | +$242K | 0.28% | 84 |
|
2020
Q1 | $315K | Buy |
10,060
+895
| +10% | +$28K | 0.16% | 147 |
|
2019
Q4 | $307K | Buy |
+9,165
| New | +$307K | 0.1% | 229 |
|